– Bio-Rad expects to make equity investment in support of deal– Agreement provides for global exclusivity in transplant monitoring commercialization– […]
MIAMI, April 11, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing […]
JOHNS CREEK, Ga., April 11, 2024 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload […]